English
Segment disclosures
Company overviewIQVIA HOLDINGS INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Commercial Solutions
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1793000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1754000000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1651000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1572000000 | USD | 20260505 | Open filing evidence |
Operating Segments · Contract Sales And Medical Solutions
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 788000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 209000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 188000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 181000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 718000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 180000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 172000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 189000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 727000000 | USD | 20260217 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 743000000 | USD | 20250213 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 784000000 | USD | 20230215 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 741000000 | USD | 20230215 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 814000000 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 208000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 604000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 203000000 | USD | 2019-07-24 · 21:23:44.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 396000000 | USD | 2019-07-24 · 21:23:44.000Z | Open filing evidence |
Operating Segments · Research And Development Solutions
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2575000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 2397000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 8896000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2260000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2366000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2257000000 Restated | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 8527000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2162000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2147000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2095000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8395000000 | USD | 20260217 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 7921000000 | USD | 20250213 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7556000000 | USD | 20230215 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5760000000 | USD | 20230215 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 5788000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1466000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 4317000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1435000000 | USD | 2019-07-24 · 21:23:44.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2851000000 | USD | 2019-07-24 · 21:23:44.000Z | Open filing evidence |
Operating Segments · Technology And Analytics Solutions
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 6626000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1631000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1628000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1546000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6160000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1554000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1495000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1453000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5862000000 | USD | 20260217 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5746000000 | USD | 20250213 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5534000000 | USD | 20230215 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 4858000000 | USD | 20230215 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1117000000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 4486000000 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1095000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 3272000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1102000000 | USD | 2019-07-24 · 21:23:44.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2177000000 | USD | 2019-07-24 · 21:23:44.000Z | Open filing evidence |
Americas · Commercial Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 895000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 856000000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 825000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 790000000 | USD | 20260505 | Open filing evidence |
Americas · Contract Sales And Medical Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 277000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 70000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 208000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 68000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 138000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 70000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 280000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 72000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 211000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 66000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 139000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 73000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 304000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 78000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 228000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 70000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 150000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 80000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 354000000 | USD | 20250213 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 88000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 179000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 91000000 | USD | 20230428 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 94000000 | USD | 20211022 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 258000000 | USD | 20211022 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 86000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 164000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 78000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 326000000 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 76000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 247000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 80000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 171000000 | USD | 20210728 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 399000000 | USD | 20210212 | Open filing evidence |
Americas · Research And Development Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1144000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2272000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1128000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 4105000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1039000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3030000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1110000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2127000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1017000000 Restated | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3894000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 969000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2969000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1014000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2000000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 986000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4157000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1017000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2982000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 979000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1965000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 986000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3747000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 960000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2772000000 | USD | 20221027 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 866000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1812000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 946000000 | USD | 20220428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3887000000 | USD | 20230215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 942000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 2911000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 935000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1969000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1034000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2680000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 628000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1826000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 528000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1198000000 | USD | 20210728 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2693000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 726000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2009000000 | USD | 20201022 | Open filing evidence |
Americas · Technology And Analytics Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 1751000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3363000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 824000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2437000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 830000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1615000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 783000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3182000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 797000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2323000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 783000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1526000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 743000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3091000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 761000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2268000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 772000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1507000000 | USD | 20240722 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2947000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 746000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2143000000 | USD | 20221027 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 716000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1397000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 681000000 | USD | 20220428 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 647000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1882000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 635000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1235000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 600000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2413000000 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 599000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1747000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 567000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1148000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 581000000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2370000000 | USD | 20210212 | Open filing evidence |
Asia Pacific · Commercial Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 211000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 210000000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 186000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 189000000 | USD | 20260505 | Open filing evidence |
Asia Pacific · Contract Sales And Medical Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 245000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 64000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 182000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 60000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 118000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 58000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 219000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 54000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 164000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 54000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 110000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 56000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 223000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 55000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 167000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 57000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 112000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 55000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 214000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 52000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 162000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 58000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 257000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 65000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 197000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 66000000 | USD | 20210728 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 132000000 | USD | 20210728 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 66000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 231000000 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 59000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 171000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 57000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 112000000 | USD | 20210728 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 215000000 | USD | 20210212 | Open filing evidence |
Asia Pacific · Research And Development Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 709000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1311000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 602000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2518000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 651000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1874000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 655000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1264000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 609000000 Restated | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2329000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 586000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1736000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 576000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1150000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 574000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2135000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 585000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1715000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 581000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1130000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 549000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2158000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 531000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1564000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 552000000 | USD | 20220722 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1033000000 | USD | 20220722 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 481000000 | USD | 20220428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1770000000 | USD | 20220216 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 463000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1303000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 449000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 840000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 391000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1413000000 | USD | 20220216 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 361000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1036000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 332000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 675000000 | USD | 20210728 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1361000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 346000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1010000000 | USD | 20201022 | Open filing evidence |
Asia Pacific · Technology And Analytics Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 421000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 617000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 155000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 453000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 152000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 375000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 146000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 581000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 131000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 422000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 143000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 291000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 148000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 615000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 151000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 457000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 153000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 306000000 | USD | 20240722 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 624000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 151000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 465000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 152000000 | USD | 20220722 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 314000000 | USD | 20220722 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 162000000 | USD | 20220428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 642000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 161000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 472000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 153000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 311000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 158000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 601000000 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 151000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 432000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 141000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 281000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 140000000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 573000000 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 146000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 422000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 276000000 | USD | 20200723 | Open filing evidence |
EMEA · Commercial Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 687000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 688000000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 640000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 593000000 | USD | 20260505 | Open filing evidence |
EMEA · Contract Sales And Medical Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 266000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 75000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 188000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 60000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 113000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 53000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 219000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 54000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 166000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 52000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 112000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 60000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 200000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 50000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 146000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 49000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 96000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 47000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 175000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 40000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 129000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 43000000 | USD | 20220722 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 89000000 | USD | 20220722 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 46000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 176000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 42000000 | USD | 20211022 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 133000000 | USD | 20211022 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 42000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 91000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 49000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 184000000 | USD | 20220216 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 44000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 134000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 40000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 90000000 | USD | 20210728 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 200000000 | USD | 20220216 | Open filing evidence |
EMEA · Research And Development Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 722000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1389000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 667000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2273000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 570000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1659000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 601000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1232000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 631000000 Restated | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2304000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 607000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1699000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 557000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1092000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 535000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2103000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 520000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1547000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 536000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1027000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 491000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2016000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 488000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1527000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 532000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1039000000 | USD | 20230801 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1899000000 | USD | 20230215 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 507000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 950000000 | USD | 20220722 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1667000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 411000000 | USD | 20201022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1214000000 | USD | 20201022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 375000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 803000000 | USD | 20210728 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1734000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 394000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1298000000 | USD | 20201022 | Open filing evidence |
EMEA · Technology And Analytics Solutions
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 1375000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2646000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 652000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1915000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 646000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1233000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 617000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2397000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 626000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1757000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 569000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1131000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 562000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2156000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 519000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1606000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 531000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1087000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 556000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2175000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 503000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1639000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 540000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1136000000 | USD | 20230801 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2282000000 | USD | 20230215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 529000000 | USD | 20211022 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1684000000 | USD | 20211022 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 565000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1155000000 | USD | 20220722 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1844000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 457000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1254000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 401000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 797000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 396000000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1543000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 369000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1128000000 | USD | 20201022 | Open filing evidence |
Commercial Solutions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1789000000 | USD | 20261027 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 1793000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1754000000 | USD | 20260505 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1673000000 | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1651000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1572000000 | USD | 20260505 | Open filing evidence |
Commercial Solutions · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1789000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1673000000 | USD | 20261027 | Open filing evidence |
Commercial Solutions · Americas
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 894000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 821000000 | USD | 20261027 | Open filing evidence |
Commercial Solutions · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 217000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 197000000 | USD | 20261027 | Open filing evidence |
Commercial Solutions · EMEA
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 678000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 655000000 | USD | 20261027 | Open filing evidence |
Contract Sales And Medical Solutions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 788000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 209000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 578000000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 188000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 369000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 181000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 718000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 180000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 541000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 172000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 361000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 189000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 727000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 183000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 541000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 176000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 358000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 182000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 743000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 183000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 561000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 183000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 378000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 195000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 784000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 201000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 588000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 194000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 387000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 193000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 741000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 179000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 552000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 177000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 373000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 196000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 814000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 208000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 604000000 | USD | 20201022 | Open filing evidence |
Contract Sales And Medical Solutions · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 727000000 | USD | 20240215 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 743000000 | USD | 20240215 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 784000000 | USD | 20240215 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 741000000 | USD | 20220216 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 196000000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 814000000 | USD | 20220216 | Open filing evidence |
Contract Sales And Medical Solutions · Americas
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 73000000 | USD | 20240502 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 304000000 | USD | 20240215 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 78000000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 228000000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 80000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 354000000 | USD | 20240215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 91000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 270000000 | USD | 20231101 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 351000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 94000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 258000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 78000000 | USD | 20210423 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 326000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 76000000 | USD | 20201022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 247000000 | USD | 20201022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 80000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 171000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 91000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 399000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 104000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 298000000 | USD | 20201022 | Open filing evidence |
Contract Sales And Medical Solutions · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 56000000 | USD | 20240502 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 55000000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 167000000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 57000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 112000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 55000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 214000000 | USD | 20230215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 52000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 162000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 52000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 110000000 | USD | 20230801 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 257000000 | USD | 20230215 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 66000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 132000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 66000000 | USD | 20210423 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 231000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 59000000 | USD | 20201022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 171000000 | USD | 20201022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 57000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 112000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 55000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 215000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 56000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 158000000 | USD | 20201022 | Open filing evidence |
Contract Sales And Medical Solutions · EMEA
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 60000000 | USD | 20240502 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 49000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 96000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 47000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 175000000 | USD | 20230215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 40000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 129000000 | USD | 20221027 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 43000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 89000000 | USD | 20230801 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 176000000 | USD | 20230215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 42000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 133000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 49000000 | USD | 20210423 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 184000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 44000000 | USD | 20201022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 134000000 | USD | 20201022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 40000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 90000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 50000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 200000000 | USD | 20200218 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 48000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 148000000 | USD | 20201022 | Open filing evidence |
Research And Development Solutions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 2639000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 7611000000 | USD | 20261027 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 2575000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4972000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 2397000000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 8896000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2427000000 Restated | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 7050000000 Restated | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2366000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4623000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2257000000 Restated | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 8527000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2162000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6404000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2147000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4242000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2095000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8395000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2122000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6244000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2096000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4122000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2026000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 7921000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1979000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 5863000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1950000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 3884000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1934000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7556000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1853000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 5612000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1891000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 3759000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1868000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5760000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1400000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4076000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1235000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2676000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1441000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 5788000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1466000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 4317000000 | USD | 20201022 | Open filing evidence |
Research And Development Solutions · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 2639000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2427000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8395000000 | USD | 20240215 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 7921000000 | USD | 20240215 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7556000000 | USD | 20240215 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1441000000 | USD | 20200430 | Open filing evidence |
Research And Development Solutions · Americas
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1193000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 3465000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1112000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3239000000 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1014000000 | USD | 20240722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2000000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4157000000 | USD | 20240215 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1017000000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2982000000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 979000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1965000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 986000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3747000000 | USD | 20240215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 960000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2772000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 946000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3887000000 | USD | 20240215 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1034000000 | USD | 20210423 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 528000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1198000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 670000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2693000000 | USD | 20200218 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 726000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2009000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
Research And Development Solutions · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 707000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2018000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 673000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1937000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2135000000 | USD | 20240215 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 581000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1130000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 549000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2158000000 | USD | 20240215 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 552000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1033000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 481000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1770000000 | USD | 20240215 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 391000000 | USD | 20210423 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1413000000 | USD | 20230215 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 332000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 675000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 343000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1361000000 | USD | 20200218 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 346000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1010000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
Research And Development Solutions · EMEA
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 739000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2128000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 642000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1874000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2103000000 | USD | 20240215 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 491000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2016000000 | USD | 20240215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 488000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1527000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 507000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1899000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 448000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1398000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 443000000 | USD | 20220428 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 411000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1214000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 375000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 803000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 428000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1734000000 | USD | 20200218 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 394000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1298000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
Technology And Analytics Solutions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 5336000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 3547000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 6626000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1631000000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4896000000 Restated | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1628000000 | USD | 20250722 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3223000000 Restated | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1546000000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6160000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1554000000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4502000000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1495000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2948000000 | USD | 20250722 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1453000000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5862000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1431000000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4331000000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1456000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2900000000 | USD | 20240722 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1444000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5746000000 | USD | 20250213 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1400000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 4247000000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1408000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2847000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1439000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5534000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1337000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 4038000000 | USD | 20221027 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1353000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 2701000000 | USD | 20220722 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1348000000 | USD | 20220428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 4858000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1207000000 | USD | 20211022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 3433000000 | USD | 20211022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1109000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2226000000 | USD | 20210728 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1117000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 4486000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1095000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 3272000000 | USD | 20201022 | Open filing evidence |
Technology And Analytics Solutions · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 5862000000 | USD | 20240215 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5746000000 | USD | 20240215 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5534000000 | USD | 20240215 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 4858000000 | USD | 20220216 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 4486000000 | USD | 20220216 | Open filing evidence |
Technology And Analytics Solutions · Americas
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 2645000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2436000000 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 743000000 | USD | 20240502 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3091000000 | USD | 20240215 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 761000000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2268000000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 735000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2947000000 | USD | 20240215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 746000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2143000000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 681000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2610000000 | USD | 20240215 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 600000000 | USD | 20210423 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2413000000 | USD | 20230215 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 599000000 | USD | 20201022 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1747000000 | USD | 20201022 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 567000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1148000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 581000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2370000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 580000000 | USD | 20201022 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1722000000 | USD | 20201022 | Open filing evidence |
Technology And Analytics Solutions · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 638000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 572000000 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 148000000 | USD | 20240502 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 153000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 306000000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 153000000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 624000000 | USD | 20230215 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 152000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 314000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 162000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 642000000 | USD | 20230215 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 158000000 | USD | 20210423 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 601000000 | USD | 20230215 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 140000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 573000000 | USD | 20220216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 146000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 422000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
Technology And Analytics Solutions · EMEA
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 2053000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1888000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2156000000 | USD | 20240215 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 556000000 | USD | 20230428 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2175000000 | USD | 20240215 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 503000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1639000000 | USD | 20221027 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 596000000 | USD | 20230428 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2282000000 | USD | 20240215 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 529000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1684000000 | USD | 20221027 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 590000000 | USD | 20220428 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 401000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 797000000 | USD | 20200723 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 396000000 | USD | 20210423 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1543000000 | USD | 20200218 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 369000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1128000000 | USD | 2019-11-01 · 11:26:08.000Z | Open filing evidence |